PEDEVCO CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that PEDEVCO CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.20M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $39.55M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $30.78M | Oct 31, 2025 |
| FY2023 | Dec 31, 2022 | $30.03M | Mar 18, 2024 |
| FY2022 | Dec 31, 2021 | $15.86M | Mar 29, 2023 |
| FY2021 | Dec 31, 2020 | $8.06M | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $12.97M | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | $4.52M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $3.02M | Apr 1, 2019 |
| FY2013 | Dec 31, 2012 | $770.0K | Mar 31, 2014 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($10.36M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $12.29M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $1.70M | Oct 31, 2025 |
| FY2023 | Dec 31, 2022 | $2.84M | Mar 18, 2024 |
| FY2022 | Dec 31, 2021 | ($1.30M) | Mar 29, 2023 |
| FY2021 | Dec 31, 2020 | ($32.69M) | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | ($11.10M) | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | $53.61M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($36.37M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($19.62M) | Mar 29, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($7.86M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $4.72M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $1.24M | Oct 31, 2025 |
| FY2023 | Dec 31, 2022 | $2.63M | Mar 18, 2024 |
| FY2022 | Dec 31, 2021 | ($1.87M) | Mar 29, 2023 |
| FY2021 | Dec 31, 2020 | ($33.82M) | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | ($10.23M) | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | ($9.00M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($23.57M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($5.66M) | Mar 29, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.79M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $6.39M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $6.01M | Oct 31, 2025 |
| FY2023 | Dec 31, 2022 | $5.85M | Mar 18, 2024 |
| FY2022 | Dec 31, 2021 | $6.21M | Mar 29, 2023 |
| FY2021 | Dec 31, 2020 | $6.74M | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $5.79M | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | $4.14M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $2.53M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $3.91M | Mar 29, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.76M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $12.77M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $23.48M | Oct 31, 2025 |
| FY2023 | Dec 31, 2022 | $15.98M | Mar 18, 2024 |
| FY2022 | Dec 31, 2021 | $5.97M | Mar 29, 2023 |
| FY2021 | Dec 31, 2020 | $12.0K | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $1.67M | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | ($1.49M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($236.0K) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($5.97M) | Mar 29, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $45.0K | Mar 18, 2024 |
| FY2023 | Dec 31, 2022 | $0 | Mar 18, 2024 |
| FY2012 | Dec 31, 2012 | $1.4K | Apr 25, 2013 |
| FY2012 | Dec 31, 2011 | $5.4K | Apr 25, 2013 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $375.87M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $128.35M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $122.74M | Oct 31, 2025 |
| FY2023 | Dec 31, 2022 | $116.11M | Mar 18, 2024 |
| FY2022 | Dec 31, 2021 | $98.22M | Mar 29, 2023 |
| FY2021 | Dec 31, 2020 | $79.56M | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $122.90M | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | $67.53M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $36.40M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $58.78M | Mar 29, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $168.51M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $12.75M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $21.29M | Oct 31, 2025 |
| FY2023 | Dec 31, 2022 | $19.65M | Mar 18, 2024 |
| FY2022 | Dec 31, 2021 | $6.74M | Mar 29, 2023 |
| FY2021 | Dec 31, 2020 | $3.93M | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $15.22M | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | $50.55M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $73.54M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $60.74M | Mar 29, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $207.36M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $115.60M | Mar 31, 2026 |
| FY2025 | Dec 31, 2023 | $101.45M | Mar 31, 2026 |
| FY2024 | Dec 31, 2022 | $97.71M | Oct 31, 2025 |
| FY2023 | Dec 31, 2021 | $91.48M | Mar 18, 2024 |
| FY2022 | Dec 31, 2020 | $75.64M | Mar 29, 2023 |
| FY2021 | Dec 31, 2019 | $105.50M | Mar 11, 2022 |
| FY2020 | Dec 31, 2018 | $16.97M | Mar 23, 2021 |
| FY2019 | Dec 31, 2017 | ($37.14M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2016 | ($1.96M) | Apr 1, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($121.86M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($111.50M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($123.79M) | Oct 31, 2025 |
| FY2023 | Dec 31, 2022 | ($126.74M) | Mar 18, 2024 |
| FY2022 | Dec 31, 2021 | ($129.59M) | Mar 29, 2023 |
| FY2021 | Dec 31, 2020 | ($128.29M) | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | ($95.60M) | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | ($84.49M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($138.10M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($101.73M) | Mar 29, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.22M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $4.01M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $18.52M | Oct 31, 2025 |
| FY2022 | Dec 31, 2022 | $29.43M | Mar 29, 2023 |
| FY2022 | Dec 31, 2021 | $25.93M | Mar 29, 2023 |
| FY2021 | Dec 31, 2020 | $8.03M | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $22.42M | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | $3.46M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $917.0K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $659.0K | Mar 29, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $0 | Mar 30, 2020 |
| FY2019 | Dec 31, 2018 | $7.69M | Mar 30, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (2) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Oct 31, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 18, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 29, 2023 |
| FY2020 | Dec 31, 2020 | 0 | Mar 23, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | 4 | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | (6) | Apr 1, 2019 |
| FY2011 | Dec 31, 2011 | 0 | Apr 16, 2012 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (2) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Oct 31, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 18, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 29, 2023 |
| FY2020 | Dec 31, 2020 | 0 | Mar 23, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | 4 | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | (6) | Apr 1, 2019 |
| FY2011 | Dec 31, 2011 | 0 | Apr 16, 2012 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4.80M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 4.47M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 87.25M | Oct 31, 2025 |
| FY2023 | Dec 31, 2022 | 85.79M | Mar 18, 2024 |
| FY2022 | Dec 31, 2021 | 84.24M | Mar 29, 2023 |
| FY2021 | Dec 31, 2020 | 72.46M | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | 71.06M | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | 15.81M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | 7.28M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | 5.49M | Mar 29, 2018 |